Supernus Pharmaceuticals, Inc.【SUPN】業績推移・財務諸表

（単位：千ドル）	1Q12	2Q12	3Q12	4Q12	1Q13	2Q13	3Q13	4Q13	1Q14	2Q14	3Q14	4Q14	1Q15	2Q15	3Q15	4Q15	1Q16	2Q16	3Q16	4Q16	1Q17	2Q17	3Q17	4Q17	1Q18	2Q18	3Q18	4Q18	1Q19	2Q19	3Q19	4Q19	1Q20	2Q20	3Q20	1Q21	2Q21	3Q21	1Q22	2Q22	3Q22	1Q23	2Q23	3Q23	1Q24	2Q24	3Q24	1Q25	2Q25
売上高	208	91	91	1,090	147	281	1,257	10,334	9,081	29,675	52,488	30,801	28,133	35,052	38,586	42,655	43,075	50,421	56,810	62,374	57,576	75,829	80,398	88,435	90,429	99,538	102,996	115,934	85,474	104,695	102,140	100,446	94,976	126,729	155,135	130,932	141,329	148,464	152,506	170,051	177,353	153,764	135,563	153,880	143,644	168,325	175,689	149,824	165,453
売上成長率（％）	-	-	-	-
売上原価	-	-	-	-	-	4	33	-	494	1,661	1,321	-	1,618	1,762	2,248	-	2,035	2,751	3,428	-	2,949	3,861	4,251	-	3,278	3,683	4,207	-	3,684	4,044	4,819	-	4,152	8,386	21,388	14,954	25,028	18,085	17,932	20,457	25,878	23,460	21,091	19,601	16,309	17,916	17,583	15,763	16,827
研究開発費	5,358	4,703	8,306	-	4,522	3,542	3,779	-	4,482	4,677	4,657	-	3,683	6,878	9,129	-	10,562	11,109	7,868	-	9,601	10,823	12,980	-	18,908	20,038	20,422	-	15,394	16,970	16,943	-	18,937	22,247	16,839	34,280	15,455	19,654	20,839	16,385	19,554	21,212	24,379	22,655	24,930	26,183	29,036	26,927	22,115
販売管理費	-	4,645	4,075	-	13,533	12,214	14,620	-	17,527	19,581	17,343	-	19,402	23,336	22,900	-	25,160	26,121	25,675	-	28,238	35,078	40,825	-	36,849	40,097	40,892	-	40,968	41,083	40,649	-	42,875	48,103	54,660	61,457	69,535	72,032	90,459	100,476	112,314	85,597	86,782	82,700	86,516	85,904	69,753	89,944	93,551
営業費用	8,086	9,348	12,381	13,834	18,055	15,760	18,432	21,691	22,503	25,919	23,321	26,072	24,703	31,976	34,277	35,806	37,757	39,981	36,971	46,078	40,788	49,762	58,056	54,091	59,035	63,818	65,521	76,079	60,046	62,097	62,411	59,630	65,964	81,181	98,995	117,718	107,216	115,860	150,539	158,705	178,876	148,588	153,150	145,742	146,797	145,756	134,844	160,080	153,312
営業利益	-7,878	-9,257	-12,290	-	-17,908	-15,479	-17,175	-	-13,422	3,756	29,167	-	3,430	3,076	4,309	-	5,318	10,440	19,839	-	16,788	26,067	22,342	34,344	31,394	35,720	37,475	39,855	25,428	42,598	39,729	40,816	29,012	45,548	56,140	13,214	34,113	32,604	1,967	11,346	-1,523	5,176	-17,587	8,138	-3,153	22,569	40,845	-10,256	12,141
営業利益率 (%)				-				-				-				-				-
経常（税引前）利益	-	-	-	-	-	-	-	-	-	-	-	-	979	2,667	4,280	-	5,185	10,732	19,136	-	16,223	26,425	22,910	-	31,182	33,856	36,371	-	24,239	42,746	39,590	-	29,034	47,210	52,711	10,929	31,235	28,960	14,723	11,324	-444	9,017	-17,127	9,889	243	26,302	44,943	-5,831	16,669
経常（税引前）利益率（％）	-	-	-	-	-	-	-	-	-	-	-	-	3.48	7.61	11.09	-	12.04	21.28	33.68	-	28.18	34.85	28.5	-	34.48	34.01	35.31	-	28.36	40.83	38.76	-	30.57	37.25	33.98	8.35	22.1	19.51	9.65	6.66	-0.25	5.86	-12.63	6.43	0.17	15.63	25.58	-3.89	10.07
法人税等合計	-	-	-	-	-	-	-	-	-	-	-	-	62	662	58	-	198	714	-42,690	-	5,926	9,057	6,949	-	4,830	3,119	8,360	-	5,899	10,019	10,730	-	7,516	12,543	12,714	5,235	7,509	7,398	-10,893	3,459	-2,193	-7,900	-16,300	25,900	100	6,400	6,446	6,000	-5,800
実効税率（％）	-	-	-	-	-	-	-	-	-	-	-	-				-				-				-				-				-
純利益	-9,277	-10,013	-13,482	-13,512	-18,414	-27,357	-24,096	-22,406	-15,543	3,202	27,858	4,354	917	2,005	4,222	6,872	4,987	10,018	61,826	14,320	10,297	17,368	15,961	13,658	26,352	30,737	28,011	25,893	18,340	32,727	28,860	33,129	21,518	34,667	39,997	5,694	23,726	21,562	25,616	7,865	1,749	16,948	-831	-15,976	124	19,916	38,497	-11,827	22,499
純利益率（％）
一株あたり利益	-	-	-	-	-	-	-	-	-	0.08	0.65	0.1	0.02	0.04	0.09	0.14	0.1	0.2	1.25	0.29	0.21	0.34	0.31	0.27	0.51	0.59	0.54	0.5	0.35	0.62	0.55	0.63	0.41	0.66	0.76	0.11	0.45	0.41	0.48	0.15	0.03	0.31	-0.02	-0.29	0	0.36	0.7	-0.21	0.4
希薄化後一株あたり利益	-	-	-	-	-	-	-	-	-	0.08	0.39	0.1	0.02	0.03	0.08	0.14	0.08	0.18	1.18	0.26	0.19	0.32	0.29	0.26	0.49	0.57	0.52	0.48	0.34	0.61	0.54	0.62	0.4	0.65	0.74	0.11	0.43	0.4	0.43	0.14	0.03	0.29	-0.02	-0.29	0	0.36	0.69	-0.21	0.4
EBITDA		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-		-	-		-	-		-	-		-	-		-
EBITDAマージン（％）		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-	-		-	-		-	-		-	-		-	-		-	-		-

Supernus Pharmaceuticals, Inc.【SUPN】 業績推移・財務諸表

Supernus Pharmaceuticals, Inc.【SUPN】業績推移・財務諸表